Skip to main content

Table 5 Effect of RES on HepG2 variant xenograft weight

From: Caveolin-1 enhances resveratrol-mediated cytotoxicity and transport in a hepatocellular carcinoma model

Group RES
(mg/kg)
n Tumor
weight/mg
Inhibitory rate % Intra-group inhibitory rate%
HepG2 0 4 222.50 ± 22.5   
HepG2 15 4 173.33 ± 33.3a 22.11 22.11
CAV1 0 4 165.50 ± 10.2 a 25.84  
CAV1 15 4 92.50 ± 15.1b 58.43 44.12
CAVM1 0 4 337.50 ± 20.6 a -51.68  
CAVM1 15 4 117.50 ± 12.5 b 47.19 65.19
CAVM2 0 4 170.00 ± 18.9 a 23.61  
CAVM2 15 4 142.50 ± 15.1 b 35.96 16.17
CAVRNAi 0 2 247.50 ± 7.07 a -11.21  
CAVRNAi 15 4 230.00 ± 6.80b -3.37 7.07
  1. Values are means ± SEM, n = 4.
  2. a. P < 0.05 vs control group.
  3. b. P < 0.05 vs corresponding untreated group (RES at doses of 0 mg/kg)